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Bureaucracy and clinical performance
To the Editor: There currently seems to be a view among managers 
in the Department of Health that the best way to improve the clinical 
performance of staff, particularly in peripheral clinics, is to increase 
the bureaucratic demands upon them.
Consider, for instance, the plight of the midwife working in a small 
clinic in KwaZulu-Natal. Hers is a very demanding task. For each 
new patient (I hate the word client) she must take the history, do the 
lab tests (haemoglobin, HIV, rhesus, a syphilis test, urine dipstick), 
take blood specimens for CD4+ and creatinine if the patient is HIV-
positive and for rhesus antibodies if she is Rh-negative, check blood 
pressure and weight, do a complete medical examination, including 
a Pap smear if the patient is booking early enough, provide the 
necessary health and post-test counselling, dispense the necessary 
medications, and in addition fill in no less than nine documents if 
the patient has HIV. They are: (i) the huge antenatal register; (ii) the 
daily clinic attendance register; (iii) the isoniazid prevention therapy 
register; (iv) the antenatal record; (v) the HAST (HIV/AIDS, sexually 
transmitted infection, tuberculosis) record; (vi)  the TB screening 
checklist; (vii) the antenatal checklist; (viii) the health education 
checklist; and (ix) the MomConnect register. These are regarded as 
necessary so that managers can have easy access to statistics, and 
they seem to be the main, often only, measure of clinical compliance 
and competence.
It is no mystery that midwives, even when assisted by enrolled 
nurses to fulfil some of these roles, struggle to keep in focus 
the obstetric problem the patient has presented with, battle to 
concentrate on relationship building, and find it hard to create time 
to structure a really logical and effective management plan. Too often 
the paperwork is intact but the clinical responses are defective, and 
the exercise has ended up defeating itself by its complexity.
This problem is not confined to the clinics. In many hospital 
wards, registered nurses spend more time meeting the bureaucratic 
demands of their employers than they do directly caring for their 
patients, and forests are decimated to produce the paper involved!
A careful rethink by senior management is required, because all 
this bureaucracy probably increases rather than decreases the rate of 
litigation, quite apart from not improving the standard of care.
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Diabetes Mellitus (DM) is considered one of the most common chronic diseases worldwide. The prevalence of DM 
(HbA1c > 6.5%) in South Africa is reported to be 9.6%, while 19% of the population has impaired glucose 
homeostasis (6.1% < HbA1c < 6.5%).1
Conclusion
The prevalence of DM in South Africa is
alarmingly high, with nearly 10% of the popu­
lation suffering from the condition. Every 
effort should be made to curb the growth in 
cases effectively. Medical nutrition therapy 
guidelines include being physically active and
following a balanced diet that includes a wide 
variety of foods. As the daily intake of dairy 
products, especially low­fat options, signifi­
cantly reduces the risk of developing DM, 
dairy should be emphasised as part of a 
healthy diet. 
Research shows that poor diet and lifestyle factors (lack of exercise and obesity) seem toplay the biggest role in the development of type 2 DM. Medical nutrition therapy guide­lines recommended for the management of DM includes following a healthy, balancedeating plan, with the optimal combination of macronutrients individualized for carbo­
hydrates and fat2. It is advised that a variety of protein sources be consumed, which is associated
with a reduction in the intake of red meat3,4 and a concomitant increase in the intake of nuts and
low­fat dairy products.1,2,5
The role of dairy consumption in DM has received considerable attention lately. However, con­
flicting results have been reported in the literature, ranging from a significant inverse association
between dairy consumption and the risk of developing type 2 DM6­10 to no significant associa­
tions.11–14 An Australian study run over five years found that dairy intake independently reduced
the risk of DM.6 In another long­term study (10 years), people with the highest intake of dairy had
a 59% lower risk of developing Metabolic Syndrome.10 Although the risk for DM was also lower in
this group, it was neither consistent nor significant. Other studies reported the intake of cheese
and fermented dairy products to be inversely associated with fasting plasma glucose and two­
hour post­prandial glucose values.11,12 Similarly, total dairy intake was not significantly associated
with the incidence of type 2 DM in the 10­year Whitehall II cohort study. Although an inverse as­
sociation was found between fermented dairy product intake and mortality, no such association
was observed with type 2 DM incidence.13
Association between the intake of dairy products and the risk of type 2 DM
Recent meta­analyses have reported consistent and significant evidence that the consumption of
dairy products reduces the risk of type 2 DM. High intake of dairy products in general was
associated with a significant reduction – between 11% and 15% – in the risk of type 2 DM7–9,14,15
and low­fat dairy consumption specifically was associated with a 10–19% lower risk of type 2
DM.7–9,15 The association appears to be independent of type of low­fat dairy product, as intakes of
low­fat milk, cheese, yoghurt and fermented dairy products were all associated with reducing the
risk of type 2 DM.7–9 In contrast, no significant association was found between the intake of full­fat 
dairy, total milk and full­fat milk7,8 and the risk of type 2 DM.
Dose–response association between dairy consumption and risk of type 2 DM
The best risk reduction was reported for total dairy intake up to 200 g per day, with the largest 
reduction associated with lower intakes.7,8 Although the association was still significant with higher 
intakes, risk reduction was more modest. No additional benefit was found with intakes exceeding 
300–400 g per day.8 For low-fat dairy, 300 g per day was reported to be associated with the best risk 
reduction.7 No additional benefit was found for intakes exceeding 400 g per day.7 Yoghurt intakes 
exceeding 120–140 g per day provided no further risk reduction.8
Possible mechanisms of action
The question can be asked whether the positive association found between dairy consumption
and reduced risk of DM could be due to the higher intake of protein and amino acids in general,
or whether it should be ascribed to the individual nutrient components of dairy.
Lower­fat dairy products produced stronger associations than full­fat dairy products, suggesting 
that dairy fat is not the only important nutrient to consider.16 For an intervention to be effective, it 
would need to address the risk factors resulting in the development of type 2 DM. Hence, mani­
pulating insulin receptor sensitivity, regulating insulin secretion and reducing insulin resistance 
could all be effective in targeting primary causes of DM. On the contrary, any changes in lifestyle­
associated risk factors (e.g. weight loss or prevention of weight gain, lower blood pressure, increased 
satiety) could be equally effective.2,17,18 Various mechanisms could therefore explain the inverse 
association between the intake of dairy products and the reduced risk of type 2 DM. 
Milk and dairy products have an abundance of calcium, magnesium and vitamin D*. The positive
effects of these nutrients include their role in increasing insulin receptor expression, improving
insulin sensitivity and beta cell function, decreasing fat absorption, increasing weight loss and
reducing blood pressure. Dairy consumption also aids in weight loss by means of increasing the
thermic effect of a meal and fat oxidation. Dairy protein, such as whey protein, is specifically
known to increase satiety and lower blood pressure pressure.7–9,14,17,19,20
The role of
dairy consumption
in preventing Type 2
Diabetes Mellitus
* Take note: South African milk is not fortifiedwith vitamin D
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